Conditions: Major Depression Bipolar Depression Schizoaffective Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 39
Healthy volunteers: no

Brief summary:
The purpose of the study is to see if galantamine HBr (Razadyne) is safe and can help treat problems with thinking and memory caused by electroconvulsive therapy (ECT).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Razadyne intervention 2: Placebo
Intervention descriptions: intervention 1: The starting dose of study medication is 4 mg twice a day intervention 2: 4 mg, 2 times a day

Protocol document: